| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.2 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.2 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.099 | 0.2 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |